Product Listing

AVENIO Tumor Tissue Analysis Kits

Overview

AVENIO Tumor Tissue Analysis Kits are a portfolio of NGS assays that provide in-house tumor profiling, comprehensive genomic profiling (CGP), and surveillance & monitoring for clinical research. Through an optimized, end-to-end workflow, the kits offer a versatile solution to evaluate DNA extracted from formalin-fixed paraffin-embedded (FFPE) tissue samples.

Key Advantages of AVENIO Tumor Tissue Analysis Kits
  • All four mutation classes (SNVs, indels, fusions and CNVs) in a single DNA workflow with exceptional sensitivity and specificity1
  • 99% success rate for FFPE tissue samples that pass input QC testing using the AVENIO QC kit included with AVENIO tumor tissue assays
  • A streamlined, end-to-end workflow from extraction to analysis and reporting in 5 days
  • An integrated solution that includes reagents, intuitive analysis and reporting to facilitate in-house adoption of high-performance NGS oncology research
Benefits of AVENIO Tumor Tissue Targeted, Expanded and Surveillance Kits:
  • Matched tissue and ctDNA panels (same genes, gene regions and hybrid-capture workflow) to facilitate concordance analysis
  • Flexibility to switch between tissue and plasma to support a variety of research applications
Benefits of AVENIO Tumor Tissue CGP Kit
  • Designed to match the 324 gene FoundationOne® CDx panel content
  • Detects genomic signatures: TMB, MSI and LOH
tumor tissue end to end workflow

References

  1. Data on file.
  2. National Comprehensive Cancer Network.  October 15, 2016.

For Research Use Only. Not for use in diagnostic procedures.

Found 0 results in
Filters
...
    ...